The trademark application Saddazyl was filed by Sana Pharma Medical AS, a corporation established under the laws of the Kingdom of Norway (the "Applicant"). The application was published for oppositions on January 27, 2022, and it was registered by office on May 6, 2022 without any oppositions.
The application was filed in English (German was selected as the second language).